Ralph La Forge

TL;DR: This document represents a continuation of the National Lipid Association recommendations developed by a diverse panel of experts who examined the evidence base and provided recommendations regarding the following topics: lifestyle therapies and strategies to improve patient outcomes by increasing adherence and using team-based collaborative care.

TL;DR: On September 16, 2012, the National Lipid Association held a Consensus Conference with the goal of better defining the effect of adiposity on lipoproteins, how the pathos of excessive body fat (adiposopathy) contributes to dyslipidemia, and how therapies such as appropriate nutrition, increased physical activity, weight-management drugs, and bariatric surgery might be expected to impact dys Lipidemia.

TL;DR: The STatin Adverse Treatment Experience survey highlights the importance of patients' adverse experiences with statins and how symptom and impact scores affect decisions to continue or discontinue therapy.

TL;DR: As the authors constantly attempt to demonstrate ways of reducing risk by improved lifestyle it behooves to re-evaluate the potential differences in gender response and adjust their expectations accordingly as clinicians.

TL;DR: A systematic approach to lipid management and cardiovascular disease risk reduction will afford meaningful opportunities for physician groups and integrated healthcare systems who aspire to reduce the unnecessary burden of premature cardiovascular disease.